Products / PRODUCT LIST

API PRODUCTS PORTFOLIO

Inke's products are high-added-value active pharmaceutical ingredients (APIs),
mainly for use in respiratory inhalation therapies

API	Indication	Micronised	CEP	EU DMF	US DMF	JP DMF	KR DMF	CN DMF	RU DMF
Aclidinium bromide	COPD			•	•
Aprepitant	Emesis	•			•
Arformoterol tartrate (A)	COPD				•			•
Arformoterol tartrate (D)^p	COPD				•			•
Asenapine maleate^p	Schizophrenia and acute mania	•
Benserazide	Parkinson's disease
Carvedilol^p	Hypertension, angina, heart failure					•
Clevidipine^p	Hypertension				•
Eletriptan HBr^p	Migraine	•				•
Enalapril maleate^p	Hypertension		•				•
Fluconazol^p	Antifungal		•		•		•
Formoterol fumarate	Asthma and COPD	•	•		•	•	•	•	•
Glycopyrrolate bromide^p	COPD	•	•		•		•	•	•
Granisetron base^p	Emesis				•
Granisetron HCl^p	Emesis		•		•	•	•
Imidapril	Hypertension			•
Indacaterol acetate	Asthma
Indacaterol maleate^p	Asthma and COPD	•		•	•		•		•
Loratadine^p	Allergy					•
Montelukast sodium^p	Asthma, allergic & seasonal rhinitis			•		•

DOWNLOAD INKE APIs PRODUCT LIST

P = Patent applications/granted patents owned by Neuraxpharm

Listed products protected by valid patents are developed solely for purposes related to the development, preparation and submission of information to obtain a Marketing Authorisation. In particular these products are under development for uses related to the activities stated in Art. 10.6 of Directive 2001/83/EC amended by the Directive 2004/27/EC of the European Parliament and of the Council of 31 March 2004, i.e. activities carried out to obtain a Marketing Authorisation. None of the products are offered for sale or supplied to countries in which they could be in conflict with valid patents.